CVM-1118 in Combination With Nivolumab for Unresectable Advanced Hepatocellular Carcinoma
CVM-1118 in Combination With Nivolumab for Unresectable Advanced Hepatocellular Carcinoma
Recruiting · NCT05257590 · Registry updated 2026-04-13Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| CVM-1118 in Combination With Nivolumab for Unresectable Advanced Hepatocellular Carcinoma | Digestive System Diseases, Digestive System Neoplasms, Liver Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, adenocarcinoma, carcinoma, epithelial neoplasm, hepatocellular carcinoma, liver disorder, neoplasm | Recruiting | Phase 2 | 2026-04-13 | NCT05257590 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| TaiRx, Inc. | 4 |
5 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Kaohsiung Chang Gung Memorial Hospital | Kaohsiung City | Taiwan | 18 |
| Keelung Chang Gung Memorial Hospital | Keelung | Taiwan | 3 |
| National Cheng Kung University Hospital | Tainan | Taiwan | 53 |
| National Taiwan University Hospital | Taipei | Taiwan | 174 |
| Taipei Veterans General Hospital | Taipei | Taiwan | 62 |